R.G.A. Jones

804 total citations
30 papers, 622 citations indexed

About

R.G.A. Jones is a scholar working on Neurology, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, R.G.A. Jones has authored 30 papers receiving a total of 622 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Neurology, 11 papers in Molecular Biology and 7 papers in Cellular and Molecular Neuroscience. Recurrent topics in R.G.A. Jones's work include Botulinum Toxin and Related Neurological Disorders (13 papers), Biochemical and Structural Characterization (7 papers) and Hereditary Neurological Disorders (6 papers). R.G.A. Jones is often cited by papers focused on Botulinum Toxin and Related Neurological Disorders (13 papers), Biochemical and Structural Characterization (7 papers) and Hereditary Neurological Disorders (6 papers). R.G.A. Jones collaborates with scholars based in United Kingdom, United States and Germany. R.G.A. Jones's co-authors include Dorothea Sesardic, J. Landon, Peter Rigsby, Yvonne Liu, Theresa Ekong, Christine Rasetti‐Escargueil, Y. Liu, Mari Ochiai, M.J. Corbel and Robert J. Tierney and has published in prestigious journals such as Analytical Biochemistry, British Journal of Pharmacology and Movement Disorders.

In The Last Decade

R.G.A. Jones

30 papers receiving 583 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R.G.A. Jones United Kingdom 15 300 180 165 85 64 30 622
M. Tamaki Japan 14 132 0.4× 86 0.5× 271 1.6× 131 1.5× 51 0.8× 25 648
Landon L. Moore United States 15 127 0.4× 64 0.4× 770 4.7× 78 0.9× 110 1.7× 23 1.2k
Abby R. Kroken United States 13 168 0.6× 122 0.7× 164 1.0× 22 0.3× 43 0.7× 18 494
Aadil El-Turabi United Kingdom 13 114 0.4× 40 0.2× 244 1.5× 37 0.4× 236 3.7× 17 742
Hiroshi Ohtsuka Japan 13 17 0.1× 49 0.3× 325 2.0× 71 0.8× 56 0.9× 57 718
Issam Hmila Tunisia 12 63 0.2× 16 0.1× 339 2.1× 137 1.6× 164 2.6× 23 557
U Weller Germany 10 54 0.2× 44 0.2× 256 1.6× 70 0.8× 108 1.7× 10 556
Andrew M. Burrage United States 8 120 0.4× 50 0.3× 224 1.4× 85 1.0× 71 1.1× 10 493
Anna Marchetti Switzerland 15 26 0.1× 70 0.4× 548 3.3× 66 0.8× 100 1.6× 33 864
Michal Gaži United States 8 43 0.1× 42 0.2× 139 0.8× 28 0.3× 56 0.9× 16 355

Countries citing papers authored by R.G.A. Jones

Since Specialization
Citations

This map shows the geographic impact of R.G.A. Jones's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R.G.A. Jones with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R.G.A. Jones more than expected).

Fields of papers citing papers by R.G.A. Jones

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R.G.A. Jones. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R.G.A. Jones. The network helps show where R.G.A. Jones may publish in the future.

Co-authorship network of co-authors of R.G.A. Jones

This figure shows the co-authorship network connecting the top 25 collaborators of R.G.A. Jones. A scholar is included among the top collaborators of R.G.A. Jones based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R.G.A. Jones. R.G.A. Jones is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jones, R.G.A., et al.. (2015). Linear models of ovine IgG1 and IgG2 subclasses and predicted pepsin cleavage sites. Journal of Pharmaceutical and Biomedical Analysis. 117. 150–154. 2 indexed citations
2.
Jones, R.G.A., et al.. (2015). Targeted localized use of therapeutic antibodies: a review of non-systemic, topical and oral applications. Critical Reviews in Biotechnology. 36(3). 1–15. 33 indexed citations
3.
Jones, R.G.A. & James D. Marks. (2013). Use of a new functional dual coating (FDC) assay to measure low toxin levels in serum and food samples following an outbreak of human botulism. Journal of Medical Microbiology. 62(6). 828–835. 8 indexed citations
4.
Rigsby, Peter, et al.. (2012). A functional dual-coated (FDC) microtiter plate method to replace the botulinum toxin LD50 test. Analytical Biochemistry. 425(1). 28–35. 26 indexed citations
5.
Hust, Michael, Yvonne Liu, Thibaut Pelat, et al.. (2011). Isolation of a nanomolar scFv inhibiting the endopeptidase activity of botulinum toxin A, by single-round panning of an immune phage-displayed library of macaque origin. BMC Biotechnology. 11(1). 113–113. 21 indexed citations
6.
Rasetti‐Escargueil, Christine, et al.. (2011). Phrenic nerve-hemidiaphragm as a highly sensitive replacement assay for determination of functional botulinum toxin antibodies. Toxicon. 57(7-8). 1008–1016. 28 indexed citations
7.
Jones, R.G.A., Yvonne Liu, Susan J. Thorpe, et al.. (2010). Release of proteolytic activity following reduction in therapeutic human serum albumin containing products: Detection with a new neoepitope endopeptidase immunoassay. Journal of Pharmaceutical and Biomedical Analysis. 54(1). 74–80. 12 indexed citations
8.
Rasetti‐Escargueil, Christine, et al.. (2009). Measurement of botulinum types A, B and E neurotoxicity using the phrenic nerve–hemidiaphragm: Improved precision with in-bred mice. Toxicon. 53(5). 503–511. 27 indexed citations
9.
Jones, R.G.A., Yvonne Liu, & Dorothea Sesardic. (2009). New highly specific botulinum type C1 endopeptidase immunoassays utilising SNAP25 or Syntaxin substrates. Journal of Immunological Methods. 343(1). 21–27. 20 indexed citations
10.
Jones, R.G.A., Yvonne Liu, Peter Rigsby, & Dorothea Sesardic. (2008). An improved method for development of toxoid vaccines and antitoxins. Journal of Immunological Methods. 337(1). 42–48. 41 indexed citations
11.
Jones, R.G.A., Mari Ochiai, Y. Liu, Theresa Ekong, & Dorothea Sesardic. (2007). Development of improved SNAP25 endopeptidase immuno-assays for botulinum type A and E toxins. Journal of Immunological Methods. 329(1-2). 92–101. 58 indexed citations
12.
Jones, R.G.A., M.J. Corbel, & Dorothea Sesardic. (2006). A review of WHO International Standards for botulinum antitoxins. Biologicals. 34(3). 223–226. 31 indexed citations
14.
Sesardic, Dorothea, et al.. (2004). Detection of antibodies against botulinum toxins. Movement Disorders. 19(S8). S85–S91. 47 indexed citations
15.
Jones, R.G.A. & J. Landon. (2003). A protocol for ‘enhanced pepsin digestion’: a step by step method for obtaining pure antibody fragments in high yield from serum. Journal of Immunological Methods. 275(1-2). 239–250. 37 indexed citations
16.
Jones, R.G.A. & J. Landon. (2002). Enhanced pepsin digestion: a novel process for purifying antibody F(ab′)2 fragments in high yield from serum. Journal of Immunological Methods. 263(1-2). 57–74. 63 indexed citations
17.
Jones, R.G.A., et al.. (1999). A novel Fab-based antivenom for the treatment of mass bee attacks.. American Journal of Tropical Medicine and Hygiene. 61(3). 361–366. 28 indexed citations
18.
Jones, R.G.A., et al.. (1999). The effects of specific antibody fragments on the ‘irreversible’ neurotoxicity induced by Brown snake (Pseudonaja) venom. British Journal of Pharmacology. 126(3). 581–584. 10 indexed citations
19.
Jones, R.G.A., et al.. (1994). Experimental evaluation of ovine antisera to Thai cobra (Naja kaouthia) venom and its α-neurotoxin. Toxicon. 32(12). 1657–1665. 13 indexed citations
20.
Jones, R.G.A., et al.. (1983). BIOLOGY AND TAXONOMY OF THE RHOPALOMYIA GALL MIDGES (DIPTERA: CECIDOMYIIDAE) OF ARTEMISIA TRIDENTATA NUTTALL (COMPOSITAE) IN IDAHO. Biodiversity Heritage Library (Smithsonian Institution). 21(1). 1–79. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026